2-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethylmonophosphate

ID: ALA574998

Chembl Id: CHEMBL574998

PubChem CID: 23263246

Max Phase: Preclinical

Molecular Formula: C6H9N2O6P

Molecular Weight: 236.12

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1ccn(CCOP(=O)(O)O)c(=O)[nH]1

Standard InChI:  InChI=1S/C6H9N2O6P/c9-5-1-2-8(6(10)7-5)3-4-14-15(11,12)13/h1-2H,3-4H2,(H,7,9,10)(H2,11,12,13)

Standard InChI Key:  DTVQZMXFZQIULD-UHFFFAOYSA-N

Alternative Forms

Associated Targets(non-human)

P2ry2 Purinergic receptor P2Y2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.12Molecular Weight (Monoisotopic): 236.0198AlogP: -1.35#Rotatable Bonds: 4
Polar Surface Area: 121.62Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 1.51CX Basic pKa: CX LogP: -1.45CX LogD: -4.73
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.56Np Likeness Score: -0.14

References

1. Sauer R, El-Tayeb A, Kaulich M, Müller CE..  (2009)  Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.,  17  (14): [PMID:19523835] [10.1016/j.bmc.2009.05.062]

Source